 Global Modified NSAIDs Market Growth 2026-2032
The global Modified NSAIDs market size is predicted to grow from US$ 7169 million in 2025 to US$ 12144 million in 2032; it is expected to grow at a CAGR of 8.3% from 2026 to 2032. Modified nonster... もっと見る
SummaryThe global Modified NSAIDs market size is predicted to grow from US$ 7169 million in 2025 to US$ 12144 million in 2032; it is expected to grow at a CAGR of 8.3% from 2026 to 2032.Modified nonsteroidal anti-inflammatory drugs (NSAIDs) are drugs developed from traditional NSAIDs (such as ibuprofen, indomethacin, and diclofenac) through molecular structure modification, improved formulation processes, or combination therapy strategies to reduce side effects and improve safety and efficacy. The main side effects of traditional NSAIDs are gastrointestinal damage, cardiovascular risk, and kidney impairment. Modified NSAIDs significantly reduce these risks and improve long-term safety through structural or formulation innovations. The product is priced at approximately $5,000 per kg, with global sales of approximately 1.46 million kg. The upstream sector consists of active pharmaceutical ingredients (COX inhibitors, synthetic intermediates); the midstream sector comprises modified formulation companies (controlled-release tablets, transdermal patches, and combination formulations); and the downstream sector includes hospitals, pharmacies, and the OTC market. Future trends are safety-driven: selective COX-2 inhibitors and novel formulations will gradually replace traditional NSAIDs, especially in the elderly and patients with chronic diseases. Precision medicine and biologics will also become complementary treatment options. United States market for Modified NSAIDs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032. China market for Modified NSAIDs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032. Europe market for Modified NSAIDs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032. Global key Modified NSAIDs players cover Pfizer, Novartis, Bayer, AbbVie, Takeda, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025. LP Information, Inc. (LPI) ' newest research report, the “Modified NSAIDs Industry Forecast” looks at past sales and reviews total world Modified NSAIDs sales in 2025, providing a comprehensive analysis by region and market sector of projected Modified NSAIDs sales for 2026 through 2032. With Modified NSAIDs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Modified NSAIDs industry. This Insight Report provides a comprehensive analysis of the global Modified NSAIDs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Modified NSAIDs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Modified NSAIDs market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Modified NSAIDs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Modified NSAIDs. This report presents a comprehensive overview, market shares, and growth opportunities of Modified NSAIDs market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: COX-2 Selective Inhibitors NO-NSAIDs (Nitric Oxide Releasers) Others Segmentation by Application Scenarios: Acute Pain Management Chronic Inflammation (Rheumatoid Arthritis, Osteoarthritis) Others Segmentation by Manufacturing Process: Sustained-Release/Controlled-Release Tablets Transdermal Patches, Gels Microencapsulated Formulations Segmentation by Application: Hospital Clinical Department Sports Medicine Others This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration. Pfizer Novartis Bayer AbbVie Takeda Sanofi GSK Johnson & Johnson Teva Sun Pharma Cipla Dr. Reddy's Aurobindo Zydus Cadila Torrent Pharma Viatris Apotex Hikma Jiangsu Hengrui Pharmaceuticals Suzhou Homesun Pharmaceutical CSPC Pharmaceutical Zhejiang Sundoc Pharmaceutical Key Questions Addressed in this Report What is the 10-year outlook for the global Modified NSAIDs market? What factors are driving Modified NSAIDs market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Modified NSAIDs market opportunities vary by end market size? How does Modified NSAIDs break out by Type, by Application? Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Modified NSAIDs Annual Sales 2021-2032 2.1.2 World Current & Future Analysis for Modified NSAIDs by Geographic Region, 2021, 2025 & 2032 2.1.3 World Current & Future Analysis for Modified NSAIDs by Country/Region, 2021, 2025 & 2032 2.2 Modified NSAIDs Segment by Type 2.2.1 COX-2 Selective Inhibitors 2.2.2 NO-NSAIDs (Nitric Oxide Releasers) 2.2.3 Others 2.2.4 Modified NSAIDs Sales by Type 2.2.4.1 Global Modified NSAIDs Sales Market Share by Type (2021-2026) 2.2.4.2 Global Modified NSAIDs Revenue and Market Share by Type (2021-2026) 2.2.4.3 Global Modified NSAIDs Sale Price by Type (2021-2026) 2.3 Modified NSAIDs Segment by Application Scenarios 2.3.1 Acute Pain Management 2.3.2 Chronic Inflammation (Rheumatoid Arthritis, Osteoarthritis) 2.3.3 Others 2.3.4 Modified NSAIDs Sales by Application Scenarios 2.3.4.1 Global Modified NSAIDs Sales Market Share by Application Scenarios (2021-2026) 2.3.4.2 Global Modified NSAIDs Revenue and Market Share by Application Scenarios (2021-2026) 2.3.4.3 Global Modified NSAIDs Sale Price by Application Scenarios (2021-2026) 2.4 Modified NSAIDs Segment by Manufacturing Process 2.4.1 Sustained-Release/Controlled-Release Tablets 2.4.2 Transdermal Patches, Gels 2.4.3 Microencapsulated Formulations 2.4.4 Modified NSAIDs Sales by Manufacturing Process 2.4.4.1 Global Modified NSAIDs Sales Market Share by Manufacturing Process (2021-2026) 2.4.4.2 Global Modified NSAIDs Revenue and Market Share by Manufacturing Process (2021-2026) 2.4.4.3 Global Modified NSAIDs Sale Price by Manufacturing Process (2021-2026) 2.5 Modified NSAIDs Segment by Application 2.5.1 Hospital Clinical Department 2.5.2 Sports Medicine 2.5.3 Others 2.5.4 Modified NSAIDs Sales by Application 2.5.4.1 Global Modified NSAIDs Sale Market Share by Application (2021-2026) 2.5.4.2 Global Modified NSAIDs Revenue and Market Share by Application (2021-2026) 2.5.4.3 Global Modified NSAIDs Sale Price by Application (2021-2026) 3 Global by Company 3.1 Global Modified NSAIDs Breakdown Data by Company 3.1.1 Global Modified NSAIDs Annual Sales by Company (2021-2026) 3.1.2 Global Modified NSAIDs Sales Market Share by Company (2021-2026) 3.2 Global Modified NSAIDs Annual Revenue by Company (2021-2026) 3.2.1 Global Modified NSAIDs Revenue by Company (2021-2026) 3.2.2 Global Modified NSAIDs Revenue Market Share by Company (2021-2026) 3.3 Global Modified NSAIDs Sale Price by Company 3.4 Key Manufacturers Modified NSAIDs Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Modified NSAIDs Product Location Distribution 3.4.2 Players Modified NSAIDs Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026) 3.6 New Products and Potential Entrants 3.7 Market M&A Activity & Strategy 4 World Historic Review for Modified NSAIDs by Geographic Region 4.1 World Historic Modified NSAIDs Market Size by Geographic Region (2021-2026) 4.1.1 Global Modified NSAIDs Annual Sales by Geographic Region (2021-2026) 4.1.2 Global Modified NSAIDs Annual Revenue by Geographic Region (2021-2026) 4.2 World Historic Modified NSAIDs Market Size by Country/Region (2021-2026) 4.2.1 Global Modified NSAIDs Annual Sales by Country/Region (2021-2026) 4.2.2 Global Modified NSAIDs Annual Revenue by Country/Region (2021-2026) 4.3 Americas Modified NSAIDs Sales Growth 4.4 APAC Modified NSAIDs Sales Growth 4.5 Europe Modified NSAIDs Sales Growth 4.6 Middle East & Africa Modified NSAIDs Sales Growth 5 Americas 5.1 Americas Modified NSAIDs Sales by Country 5.1.1 Americas Modified NSAIDs Sales by Country (2021-2026) 5.1.2 Americas Modified NSAIDs Revenue by Country (2021-2026) 5.2 Americas Modified NSAIDs Sales by Type (2021-2026) 5.3 Americas Modified NSAIDs Sales by Application (2021-2026) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Modified NSAIDs Sales by Region 6.1.1 APAC Modified NSAIDs Sales by Region (2021-2026) 6.1.2 APAC Modified NSAIDs Revenue by Region (2021-2026) 6.2 APAC Modified NSAIDs Sales by Type (2021-2026) 6.3 APAC Modified NSAIDs Sales by Application (2021-2026) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Modified NSAIDs by Country 7.1.1 Europe Modified NSAIDs Sales by Country (2021-2026) 7.1.2 Europe Modified NSAIDs Revenue by Country (2021-2026) 7.2 Europe Modified NSAIDs Sales by Type (2021-2026) 7.3 Europe Modified NSAIDs Sales by Application (2021-2026) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Modified NSAIDs by Country 8.1.1 Middle East & Africa Modified NSAIDs Sales by Country (2021-2026) 8.1.2 Middle East & Africa Modified NSAIDs Revenue by Country (2021-2026) 8.2 Middle East & Africa Modified NSAIDs Sales by Type (2021-2026) 8.3 Middle East & Africa Modified NSAIDs Sales by Application (2021-2026) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Modified NSAIDs 10.3 Manufacturing Process Analysis of Modified NSAIDs 10.4 Industry Chain Structure of Modified NSAIDs 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Modified NSAIDs Distributors 11.3 Modified NSAIDs Customer 12 World Forecast Review for Modified NSAIDs by Geographic Region 12.1 Global Modified NSAIDs Market Size Forecast by Region 12.1.1 Global Modified NSAIDs Forecast by Region (2027-2032) 12.1.2 Global Modified NSAIDs Annual Revenue Forecast by Region (2027-2032) 12.2 Americas Forecast by Country (2027-2032) 12.3 APAC Forecast by Region (2027-2032) 12.4 Europe Forecast by Country (2027-2032) 12.5 Middle East & Africa Forecast by Country (2027-2032) 12.6 Global Modified NSAIDs Forecast by Type (2027-2032) 12.7 Global Modified NSAIDs Forecast by Application (2027-2032) 13 Key Players Analysis 13.1 Pfizer 13.1.1 Pfizer Company Information 13.1.2 Pfizer Modified NSAIDs Product Portfolios and Specifications 13.1.3 Pfizer Modified NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026) 13.1.4 Pfizer Main Business Overview 13.1.5 Pfizer Latest Developments 13.2 Novartis 13.2.1 Novartis Company Information 13.2.2 Novartis Modified NSAIDs Product Portfolios and Specifications 13.2.3 Novartis Modified NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026) 13.2.4 Novartis Main Business Overview 13.2.5 Novartis Latest Developments 13.3 Bayer 13.3.1 Bayer Company Information 13.3.2 Bayer Modified NSAIDs Product Portfolios and Specifications 13.3.3 Bayer Modified NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026) 13.3.4 Bayer Main Business Overview 13.3.5 Bayer Latest Developments 13.4 AbbVie 13.4.1 AbbVie Company Information 13.4.2 AbbVie Modified NSAIDs Product Portfolios and Specifications 13.4.3 AbbVie Modified NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026) 13.4.4 AbbVie Main Business Overview 13.4.5 AbbVie Latest Developments 13.5 Takeda 13.5.1 Takeda Company Information 13.5.2 Takeda Modified NSAIDs Product Portfolios and Specifications 13.5.3 Takeda Modified NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026) 13.5.4 Takeda Main Business Overview 13.5.5 Takeda Latest Developments 13.6 Sanofi 13.6.1 Sanofi Company Information 13.6.2 Sanofi Modified NSAIDs Product Portfolios and Specifications 13.6.3 Sanofi Modified NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026) 13.6.4 Sanofi Main Business Overview 13.6.5 Sanofi Latest Developments 13.7 GSK 13.7.1 GSK Company Information 13.7.2 GSK Modified NSAIDs Product Portfolios and Specifications 13.7.3 GSK Modified NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026) 13.7.4 GSK Main Business Overview 13.7.5 GSK Latest Developments 13.8 Johnson & Johnson 13.8.1 Johnson & Johnson Company Information 13.8.2 Johnson & Johnson Modified NSAIDs Product Portfolios and Specifications 13.8.3 Johnson & Johnson Modified NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026) 13.8.4 Johnson & Johnson Main Business Overview 13.8.5 Johnson & Johnson Latest Developments 13.9 Teva 13.9.1 Teva Company Information 13.9.2 Teva Modified NSAIDs Product Portfolios and Specifications 13.9.3 Teva Modified NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026) 13.9.4 Teva Main Business Overview 13.9.5 Teva Latest Developments 13.10 Sun Pharma 13.10.1 Sun Pharma Company Information 13.10.2 Sun Pharma Modified NSAIDs Product Portfolios and Specifications 13.10.3 Sun Pharma Modified NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026) 13.10.4 Sun Pharma Main Business Overview 13.10.5 Sun Pharma Latest Developments 13.11 Cipla 13.11.1 Cipla Company Information 13.11.2 Cipla Modified NSAIDs Product Portfolios and Specifications 13.11.3 Cipla Modified NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026) 13.11.4 Cipla Main Business Overview 13.11.5 Cipla Latest Developments 13.12 Dr. Reddy's 13.12.1 Dr. Reddy's Company Information 13.12.2 Dr. Reddy's Modified NSAIDs Product Portfolios and Specifications 13.12.3 Dr. Reddy's Modified NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026) 13.12.4 Dr. Reddy's Main Business Overview 13.12.5 Dr. Reddy's Latest Developments 13.13 Aurobindo 13.13.1 Aurobindo Company Information 13.13.2 Aurobindo Modified NSAIDs Product Portfolios and Specifications 13.13.3 Aurobindo Modified NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026) 13.13.4 Aurobindo Main Business Overview 13.13.5 Aurobindo Latest Developments 13.14 Zydus Cadila 13.14.1 Zydus Cadila Company Information 13.14.2 Zydus Cadila Modified NSAIDs Product Portfolios and Specifications 13.14.3 Zydus Cadila Modified NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026) 13.14.4 Zydus Cadila Main Business Overview 13.14.5 Zydus Cadila Latest Developments 13.15 Torrent Pharma 13.15.1 Torrent Pharma Company Information 13.15.2 Torrent Pharma Modified NSAIDs Product Portfolios and Specifications 13.15.3 Torrent Pharma Modified NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026) 13.15.4 Torrent Pharma Main Business Overview 13.15.5 Torrent Pharma Latest Developments 13.16 Viatris 13.16.1 Viatris Company Information 13.16.2 Viatris Modified NSAIDs Product Portfolios and Specifications 13.16.3 Viatris Modified NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026) 13.16.4 Viatris Main Business Overview 13.16.5 Viatris Latest Developments 13.17 Apotex 13.17.1 Apotex Company Information 13.17.2 Apotex Modified NSAIDs Product Portfolios and Specifications 13.17.3 Apotex Modified NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026) 13.17.4 Apotex Main Business Overview 13.17.5 Apotex Latest Developments 13.18 Hikma 13.18.1 Hikma Company Information 13.18.2 Hikma Modified NSAIDs Product Portfolios and Specifications 13.18.3 Hikma Modified NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026) 13.18.4 Hikma Main Business Overview 13.18.5 Hikma Latest Developments 13.19 Jiangsu Hengrui Pharmaceuticals 13.19.1 Jiangsu Hengrui Pharmaceuticals Company Information 13.19.2 Jiangsu Hengrui Pharmaceuticals Modified NSAIDs Product Portfolios and Specifications 13.19.3 Jiangsu Hengrui Pharmaceuticals Modified NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026) 13.19.4 Jiangsu Hengrui Pharmaceuticals Main Business Overview 13.19.5 Jiangsu Hengrui Pharmaceuticals Latest Developments 13.20 Suzhou Homesun Pharmaceutical 13.20.1 Suzhou Homesun Pharmaceutical Company Information 13.20.2 Suzhou Homesun Pharmaceutical Modified NSAIDs Product Portfolios and Specifications 13.20.3 Suzhou Homesun Pharmaceutical Modified NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026) 13.20.4 Suzhou Homesun Pharmaceutical Main Business Overview 13.20.5 Suzhou Homesun Pharmaceutical Latest Developments 13.21 CSPC Pharmaceutical 13.21.1 CSPC Pharmaceutical Company Information 13.21.2 CSPC Pharmaceutical Modified NSAIDs Product Portfolios and Specifications 13.21.3 CSPC Pharmaceutical Modified NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026) 13.21.4 CSPC Pharmaceutical Main Business Overview 13.21.5 CSPC Pharmaceutical Latest Developments 13.22 Zhejiang Sundoc Pharmaceutical 13.22.1 Zhejiang Sundoc Pharmaceutical Company Information 13.22.2 Zhejiang Sundoc Pharmaceutical Modified NSAIDs Product Portfolios and Specifications 13.22.3 Zhejiang Sundoc Pharmaceutical Modified NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026) 13.22.4 Zhejiang Sundoc Pharmaceutical Main Business Overview 13.22.5 Zhejiang Sundoc Pharmaceutical Latest Developments 14 Research Findings and Conclusion List of Tables/GraphsList of TablesTable 1. Modified NSAIDs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions) Table 2. Modified NSAIDs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions) Table 3. Major Players of COX-2 Selective Inhibitors Table 4. Major Players of NO-NSAIDs (Nitric Oxide Releasers) Table 5. Major Players of Others Table 6. Global Modified NSAIDs Sales by Type (2021-2026) & (Tons) Table 7. Global Modified NSAIDs Sales Market Share by Type (2021-2026) Table 8. Global Modified NSAIDs Revenue by Type (2021-2026) & ($ million) Table 9. Global Modified NSAIDs Revenue Market Share by Type (2021-2026) Table 10. Global Modified NSAIDs Sale Price by Type (2021-2026) & (US$/kg) Table 11. Major Players of Acute Pain Management Table 12. Major Players of Chronic Inflammation (Rheumatoid Arthritis, Osteoarthritis) Table 13. Major Players of Others Table 14. Global Modified NSAIDs Sales by Application Scenarios (2021-2026) & (Tons) Table 15. Global Modified NSAIDs Sales Market Share by Application Scenarios (2021-2026) Table 16. Global Modified NSAIDs Revenue by Application Scenarios (2021-2026) & ($ million) Table 17. Global Modified NSAIDs Revenue Market Share by Application Scenarios (2021-2026) Table 18. Global Modified NSAIDs Sale Price by Application Scenarios (2021-2026) & (US$/kg) Table 19. Major Players of Sustained-Release/Controlled-Release Tablets Table 20. Major Players of Transdermal Patches, Gels Table 21. Major Players of Microencapsulated Formulations Table 22. Global Modified NSAIDs Sales by Manufacturing Process (2021-2026) & (Tons) Table 23. Global Modified NSAIDs Sales Market Share by Manufacturing Process (2021-2026) Table 24. Global Modified NSAIDs Revenue by Manufacturing Process (2021-2026) & ($ million) Table 25. Global Modified NSAIDs Revenue Market Share by Manufacturing Process (2021-2026) Table 26. Global Modified NSAIDs Sale Price by Manufacturing Process (2021-2026) & (US$/kg) Table 27. Global Modified NSAIDs Sale by Application (2021-2026) & (Tons) Table 28. Global Modified NSAIDs Sale Market Share by Application (2021-2026) Table 29. Global Modified NSAIDs Revenue by Application (2021-2026) & ($ million) Table 30. Global Modified NSAIDs Revenue Market Share by Application (2021-2026) Table 31. Global Modified NSAIDs Sale Price by Application (2021-2026) & (US$/kg) Table 32. Global Modified NSAIDs Sales by Company (2021-2026) & (Tons) Table 33. Global Modified NSAIDs Sales Market Share by Company (2021-2026) Table 34. Global Modified NSAIDs Revenue by Company (2021-2026) & ($ millions) Table 35. Global Modified NSAIDs Revenue Market Share by Company (2021-2026) Table 36. Global Modified NSAIDs Sale Price by Company (2021-2026) & (US$/kg) Table 37. Key Manufacturers Modified NSAIDs Producing Area Distribution and Sales Area Table 38. Players Modified NSAIDs Products Offered Table 39. Modified NSAIDs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026) Table 40. New Products and Potential Entrants Table 41. Market M&A Activity & Strategy Table 42. Global Modified NSAIDs Sales by Geographic Region (2021-2026) & (Tons) Table 43. Global Modified NSAIDs Sales Market Share Geographic Region (2021-2026) Table 44. Global Modified NSAIDs Revenue by Geographic Region (2021-2026) & ($ millions) Table 45. Global Modified NSAIDs Revenue Market Share by Geographic Region (2021-2026) Table 46. Global Modified NSAIDs Sales by Country/Region (2021-2026) & (Tons) Table 47. Global Modified NSAIDs Sales Market Share by Country/Region (2021-2026) Table 48. Global Modified NSAIDs Revenue by Country/Region (2021-2026) & ($ millions) Table 49. Global Modified NSAIDs Revenue Market Share by Country/Region (2021-2026) Table 50. Americas Modified NSAIDs Sales by Country (2021-2026) & (Tons) Table 51. Americas Modified NSAIDs Sales Market Share by Country (2021-2026) Table 52. Americas Modified NSAIDs Revenue by Country (2021-2026) & ($ millions) Table 53. Americas Modified NSAIDs Sales by Type (2021-2026) & (Tons) Table 54. Americas Modified NSAIDs Sales by Application (2021-2026) & (Tons) Table 55. APAC Modified NSAIDs Sales by Region (2021-2026) & (Tons) Table 56. APAC Modified NSAIDs Sales Market Share by Region (2021-2026) Table 57. APAC Modified NSAIDs Revenue by Region (2021-2026) & ($ millions) Table 58. APAC Modified NSAIDs Sales by Type (2021-2026) & (Tons) Table 59. APAC Modified NSAIDs Sales by Application (2021-2026) & (Tons) Table 60. Europe Modified NSAIDs Sales by Country (2021-2026) & (Tons) Table 61. Europe Modified NSAIDs Revenue by Country (2021-2026) & ($ millions) Table 62. Europe Modified NSAIDs Sales by Type (2021-2026) & (Tons) Table 63. Europe Modified NSAIDs Sales by Application (2021-2026) & (Tons) Table 64. Middle East & Africa Modified NSAIDs Sales by Country (2021-2026) & (Tons) Table 65. Middle East & Africa Modified NSAIDs Revenue Market Share by Country (2021-2026) Table 66. Middle East & Africa Modified NSAIDs Sales by Type (2021-2026) & (Tons) Table 67. Middle East & Africa Modified NSAIDs Sales by Application (2021-2026) & (Tons) Table 68. Key Market Drivers & Growth Opportunities of Modified NSAIDs Table 69. Key Market Challenges & Risks of Modified NSAIDs Table 70. Key Industry Trends of Modified NSAIDs Table 71. Modified NSAIDs Raw Material Table 72. Key Suppliers of Raw Materials Table 73. Modified NSAIDs Distributors List Table 74. Modified NSAIDs Customer List Table 75. Global Modified NSAIDs Sales Forecast by Region (2027-2032) & (Tons) Table 76. Global Modified NSAIDs Revenue Forecast by Region (2027-2032) & ($ millions) Table 77. Americas Modified NSAIDs Sales Forecast by Country (2027-2032) & (Tons) Table 78. Americas Modified NSAIDs Annual Revenue Forecast by Country (2027-2032) & ($ millions) Table 79. APAC Modified NSAIDs Sales Forecast by Region (2027-2032) & (Tons) Table 80. APAC Modified NSAIDs Annual Revenue Forecast by Region (2027-2032) & ($ millions) Table 81. Europe Modified NSAIDs Sales Forecast by Country (2027-2032) & (Tons) Table 82. Europe Modified NSAIDs Revenue Forecast by Country (2027-2032) & ($ millions) Table 83. Middle East & Africa Modified NSAIDs Sales Forecast by Country (2027-2032) & (Tons) Table 84. Middle East & Africa Modified NSAIDs Revenue Forecast by Country (2027-2032) & ($ millions) Table 85. Global Modified NSAIDs Sales Forecast by Type (2027-2032) & (Tons) Table 86. Global Modified NSAIDs Revenue Forecast by Type (2027-2032) & ($ millions) Table 87. Global Modified NSAIDs Sales Forecast by Application (2027-2032) & (Tons) Table 88. Global Modified NSAIDs Revenue Forecast by Application (2027-2032) & ($ millions) Table 89. Pfizer Basic Information, Modified NSAIDs Manufacturing Base, Sales Area and Its Competitors Table 90. Pfizer Modified NSAIDs Product Portfolios and Specifications Table 91. Pfizer Modified NSAIDs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 92. Pfizer Main Business Table 93. Pfizer Latest Developments Table 94. Novartis Basic Information, Modified NSAIDs Manufacturing Base, Sales Area and Its Competitors Table 95. Novartis Modified NSAIDs Product Portfolios and Specifications Table 96. Novartis Modified NSAIDs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 97. Novartis Main Business Table 98. Novartis Latest Developments Table 99. Bayer Basic Information, Modified NSAIDs Manufacturing Base, Sales Area and Its Competitors Table 100. Bayer Modified NSAIDs Product Portfolios and Specifications Table 101. Bayer Modified NSAIDs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 102. Bayer Main Business Table 103. Bayer Latest Developments Table 104. AbbVie Basic Information, Modified NSAIDs Manufacturing Base, Sales Area and Its Competitors Table 105. AbbVie Modified NSAIDs Product Portfolios and Specifications Table 106. AbbVie Modified NSAIDs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 107. AbbVie Main Business Table 108. AbbVie Latest Developments Table 109. Takeda Basic Information, Modified NSAIDs Manufacturing Base, Sales Area and Its Competitors Table 110. Takeda Modified NSAIDs Product Portfolios and Specifications Table 111. Takeda Modified NSAIDs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 112. Takeda Main Business Table 113. Takeda Latest Developments Table 114. Sanofi Basic Information, Modified NSAIDs Manufacturing Base, Sales Area and Its Competitors Table 115. Sanofi Modified NSAIDs Product Portfolios and Specifications Table 116. Sanofi Modified NSAIDs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 117. Sanofi Main Business Table 118. Sanofi Latest Developments Table 119. GSK Basic Information, Modified NSAIDs Manufacturing Base, Sales Area and Its Competitors Table 120. GSK Modified NSAIDs Product Portfolios and Specifications Table 121. GSK Modified NSAIDs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 122. GSK Main Business Table 123. GSK Latest Developments Table 124. Johnson & Johnson Basic Information, Modified NSAIDs Manufacturing Base, Sales Area and Its Competitors Table 125. Johnson & Johnson Modified NSAIDs Product Portfolios and Specifications Table 126. Johnson & Johnson Modified NSAIDs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 127. Johnson & Johnson Main Business Table 128. Johnson & Johnson Latest Developments Table 129. Teva Basic Information, Modified NSAIDs Manufacturing Base, Sales Area and Its Competitors Table 130. Teva Modified NSAIDs Product Portfolios and Specifications Table 131. Teva Modified NSAIDs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 132. Teva Main Business Table 133. Teva Latest Developments Table 134. Sun Pharma Basic Information, Modified NSAIDs Manufacturing Base, Sales Area and Its Competitors Table 135. Sun Pharma Modified NSAIDs Product Portfolios and Specifications Table 136. Sun Pharma Modified NSAIDs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 137. Sun Pharma Main Business Table 138. Sun Pharma Latest Developments Table 139. Cipla Basic Information, Modified NSAIDs Manufacturing Base, Sales Area and Its Competitors Table 140. Cipla Modified NSAIDs Product Portfolios and Specifications Table 141. Cipla Modified NSAIDs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 142. Cipla Main Business Table 143. Cipla Latest Developments Table 144. Dr. Reddy's Basic Information, Modified NSAIDs Manufacturing Base, Sales Area and Its Competitors Table 145. Dr. Reddy's Modified NSAIDs Product Portfolios and Specifications Table 146. Dr. Reddy's Modified NSAIDs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 147. Dr. Reddy's Main Business Table 148. Dr. Reddy's Latest Developments Table 149. Aurobindo Basic Information, Modified NSAIDs Manufacturing Base, Sales Area and Its Competitors Table 150. Aurobindo Modified NSAIDs Product Portfolios and Specifications Table 151. Aurobindo Modified NSAIDs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 152. Aurobindo Main Business Table 153. Aurobindo Latest Developments Table 154. Zydus Cadila Basic Information, Modified NSAIDs Manufacturing Base, Sales Area and Its Competitors Table 155. Zydus Cadila Modified NSAIDs Product Portfolios and Specifications Table 156. Zydus Cadila Modified NSAIDs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 157. Zydus Cadila Main Business Table 158. Zydus Cadila Latest Developments Table 159. Torrent Pharma Basic Information, Modified NSAIDs Manufacturing Base, Sales Area and Its Competitors Table 160. Torrent Pharma Modified NSAIDs Product Portfolios and Specifications Table 161. Torrent Pharma Modified NSAIDs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 162. Torrent Pharma Main Business Table 163. Torrent Pharma Latest Developments Table 164. Viatris Basic Information, Modified NSAIDs Manufacturing Base, Sales Area and Its Competitors Table 165. Viatris Modified NSAIDs Product Portfolios and Specifications Table 166. Viatris Modified NSAIDs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 167. Viatris Main Business Table 168. Viatris Latest Developments Table 169. Apotex Basic Information, Modified NSAIDs Manufacturing Base, Sales Area and Its Competitors Table 170. Apotex Modified NSAIDs Product Portfolios and Specifications Table 171. Apotex Modified NSAIDs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 172. Apotex Main Business Table 173. Apotex Latest Developments Table 174. Hikma Basic Information, Modified NSAIDs Manufacturing Base, Sales Area and Its Competitors Table 175. Hikma Modified NSAIDs Product Portfolios and Specifications Table 176. Hikma Modified NSAIDs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 177. Hikma Main Business Table 178. Hikma Latest Developments Table 179. Jiangsu Hengrui Pharmaceuticals Basic Information, Modified NSAIDs Manufacturing Base, Sales Area and Its Competitors Table 180. Jiangsu Hengrui Pharmaceuticals Modified NSAIDs Product Portfolios and Specifications Table 181. Jiangsu Hengrui Pharmaceuticals Modified NSAIDs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 182. Jiangsu Hengrui Pharmaceuticals Main Business Table 183. Jiangsu Hengrui Pharmaceuticals Latest Developments Table 184. Suzhou Homesun Pharmaceutical Basic Information, Modified NSAIDs Manufacturing Base, Sales Area and Its Competitors Table 185. Suzhou Homesun Pharmaceutical Modified NSAIDs Product Portfolios and Specifications Table 186. Suzhou Homesun Pharmaceutical Modified NSAIDs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 187. Suzhou Homesun Pharmaceutical Main Business Table 188. Suzhou Homesun Pharmaceutical Latest Developments Table 189. CSPC Pharmaceutical Basic Information, Modified NSAIDs Manufacturing Base, Sales Area and Its Competitors Table 190. CSPC Pharmaceutical Modified NSAIDs Product Portfolios and Specifications Table 191. CSPC Pharmaceutical Modified NSAIDs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 192. CSPC Pharmaceutical Main Business Table 193. CSPC Pharmaceutical Latest Developments Table 194. Zhejiang Sundoc Pharmaceutical Basic Information, Modified NSAIDs Manufacturing Base, Sales Area and Its Competitors Table 195. Zhejiang Sundoc Pharmaceutical Modified NSAIDs Product Portfolios and Specifications Table 196. Zhejiang Sundoc Pharmaceutical Modified NSAIDs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 197. Zhejiang Sundoc Pharmaceutical Main Business Table 198. Zhejiang Sundoc Pharmaceutical Latest Developments List of Figures Figure 1. Picture of Modified NSAIDs Figure 2. Modified NSAIDs Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Modified NSAIDs Sales Growth Rate 2021-2032 (Tons) Figure 7. Global Modified NSAIDs Revenue Growth Rate 2021-2032 ($ millions) Figure 8. Modified NSAIDs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions) Figure 9. Modified NSAIDs Sales Market Share by Country/Region (2025) Figure 10. Modified NSAIDs Sales Market Share by Country/Region (2021, 2025 & 2032) Figure 11. Product Picture of COX-2 Selective Inhibitors Figure 12. Product Picture of NO-NSAIDs (Nitric Oxide Releasers) Figure 13. Product Picture of Others Figure 14. Global Modified NSAIDs Sales Market Share by Type in 2026 Figure 15. Global Modified NSAIDs Revenue Market Share by Type (2021-2026) Figure 16. Product Picture of Acute Pain Management Figure 17. Product Picture of Chronic Inflammation (Rheumatoid Arthritis, Osteoarthritis) Figure 18. Product Picture of Others Figure 19. Global Modified NSAIDs Sales Market Share by Application Scenarios in 2026 Figure 20. Global Modified NSAIDs Revenue Market Share by Application Scenarios (2021-2026) Figure 21. Product Picture of Sustained-Release/Controlled-Release Tablets Figure 22. Product Picture of Transdermal Patches, Gels Figure 23. Product Picture of Microencapsulated Formulations Figure 24. Global Modified NSAIDs Sales Market Share by Manufacturing Process in 2026 Figure 25. Global Modified NSAIDs Revenue Market Share by Manufacturing Process (2021-2026) Figure 26. Modified NSAIDs Consumed in Hospital Clinical Department Figure 27. Global Modified NSAIDs Market: Hospital Clinical Department (2021-2026) & (Tons) Figure 28. Modified NSAIDs Consumed in Sports Medicine Figure 29. Global Modified NSAIDs Market: Sports Medicine (2021-2026) & (Tons) Figure 30. Modified NSAIDs Consumed in Others Figure 31. Global Modified NSAIDs Market: Others (2021-2026) & (Tons) Figure 32. Global Modified NSAIDs Sale Market Share by Application (2025) Figure 33. Global Modified NSAIDs Revenue Market Share by Application in 2026 Figure 34. Modified NSAIDs Sales by Company in 2026 (Tons) Figure 35. Global Modified NSAIDs Sales Market Share by Company in 2026 Figure 36. Modified NSAIDs Revenue by Company in 2026 ($ millions) Figure 37. Global Modified NSAIDs Revenue Market Share by Company in 2026 Figure 38. Global Modified NSAIDs Sales Market Share by Geographic Region (2021-2026) Figure 39. Global Modified NSAIDs Revenue Market Share by Geographic Region in 2026 Figure 40. Americas Modified NSAIDs Sales 2021-2026 (Tons) Figure 41. Americas Modified NSAIDs Revenue 2021-2026 ($ millions) Figure 42. APAC Modified NSAIDs Sales 2021-2026 (Tons) Figure 43. APAC Modified NSAIDs Revenue 2021-2026 ($ millions) Figure 44. Europe Modified NSAIDs Sales 2021-2026 (Tons) Figure 45. Europe Modified NSAIDs Revenue 2021-2026 ($ millions) Figure 46. Middle East & Africa Modified NSAIDs Sales 2021-2026 (Tons) Figure 47. Middle East & Africa Modified NSAIDs Revenue 2021-2026 ($ millions) Figure 48. Americas Modified NSAIDs Sales Market Share by Country in 2026 Figure 49. Americas Modified NSAIDs Revenue Market Share by Country (2021-2026) Figure 50. Americas Modified NSAIDs Sales Market Share by Type (2021-2026) Figure 51. Americas Modified NSAIDs Sales Market Share by Application (2021-2026) Figure 52. United States Modified NSAIDs Revenue Growth 2021-2026 ($ millions) Figure 53. Canada Modified NSAIDs Revenue Growth 2021-2026 ($ millions) Figure 54. Mexico Modified NSAIDs Revenue Growth 2021-2026 ($ millions) Figure 55. Brazil Modified NSAIDs Revenue Growth 2021-2026 ($ millions) Figure 56. APAC Modified NSAIDs Sales Market Share by Region in 2026 Figure 57. APAC Modified NSAIDs Revenue Market Share by Region (2021-2026) Figure 58. APAC Modified NSAIDs Sales Market Share by Type (2021-2026) Figure 59. APAC Modified NSAIDs Sales Market Share by Application (2021-2026) Figure 60. China Modified NSAIDs Revenue Growth 2021-2026 ($ millions) Figure 61. Japan Modified NSAIDs Revenue Growth 2021-2026 ($ millions) Figure 62. South Korea Modified NSAIDs Revenue Growth 2021-2026 ($ millions) Figure 63. Southeast Asia Modified NSAIDs Revenue Growth 2021-2026 ($ millions) Figure 64. India Modified NSAIDs Revenue Growth 2021-2026 ($ millions) Figure 65. Australia Modified NSAIDs Revenue Growth 2021-2026 ($ millions) Figure 66. China Taiwan Modified NSAIDs Revenue Growth 2021-2026 ($ millions) Figure 67. Europe Modified NSAIDs Sales Market Share by Country in 2026 Figure 68. Europe Modified NSAIDs Revenue Market Share by Country (2021-2026) Figure 69. Europe Modified NSAIDs Sales Market Share by Type (2021-2026) Figure 70. Europe Modified NSAIDs Sales Market Share by Application (2021-2026) Figure 71. Germany Modified NSAIDs Revenue Growth 2021-2026 ($ millions) Figure 72. France Modified NSAIDs Revenue Growth 2021-2026 ($ millions) Figure 73. UK Modified NSAIDs Revenue Growth 2021-2026 ($ millions) Figure 74. Italy Modified NSAIDs Revenue Growth 2021-2026 ($ millions) Figure 75. Russia Modified NSAIDs Revenue Growth 2021-2026 ($ millions) Figure 76. Middle East & Africa Modified NSAIDs Sales Market Share by Country (2021-2026) Figure 77. Middle East & Africa Modified NSAIDs Sales Market Share by Type (2021-2026) Figure 78. Middle East & Africa Modified NSAIDs Sales Market Share by Application (2021-2026) Figure 79. Egypt Modified NSAIDs Revenue Growth 2021-2026 ($ millions) Figure 80. South Africa Modified NSAIDs Revenue Growth 2021-2026 ($ millions) Figure 81. Israel Modified NSAIDs Revenue Growth 2021-2026 ($ millions) Figure 82. Turkey Modified NSAIDs Revenue Growth 2021-2026 ($ millions) Figure 83. GCC Countries Modified NSAIDs Revenue Growth 2021-2026 ($ millions) Figure 84. Manufacturing Cost Structure Analysis of Modified NSAIDs in 2026 Figure 85. Manufacturing Process Analysis of Modified NSAIDs Figure 86. Industry Chain Structure of Modified NSAIDs Figure 87. Channels of Distribution Figure 88. Global Modified NSAIDs Sales Market Forecast by Region (2027-2032) Figure 89. Global Modified NSAIDs Revenue Market Share Forecast by Region (2027-2032) Figure 90. Global Modified NSAIDs Sales Market Share Forecast by Type (2027-2032) Figure 91. Global Modified NSAIDs Revenue Market Share Forecast by Type (2027-2032) Figure 92. Global Modified NSAIDs Sales Market Share Forecast by Application (2027-2032) Figure 93. Global Modified NSAIDs Revenue Market Share Forecast by Application (2027-2032)
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医薬）の最新刊レポート
LP Information社の 医薬品・ヘルスケア分野 での最新刊レポート
よくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
